Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2005;330:360-361 (12 February), doi:10.1136/bmj.330.7487.360-b
| The first 150 words of the full text of this article appear below. |
EDITORThe campaign to promote academic medicine represents an important effort to deal with the many challenges facing international clinical research.1 Particularly, since this campaign is led by a group of academic publishers, asking if or how these challenges have been reflected in the biomedical literature is worth while. To investigate this issue, we examined all 8.1 million articles indexed in Medline between 1994 and 2001, comparing three eras: 1978-85, 1986-93, and 1994-2001.
The proportion of studies including human subjects (the most common proxy for clinical research) increased significantly during the study period from 62.6% to 68.8% (P < 0.001). While absolute rates of funding rose over time for both groups, they increased more rapidly for studies not involving human subjects, leading to a widening funding gap between these papers and clinical manuscripts (table). By the final study era (1994-2001), more than two thirds of clinical publications
Benjamin G Druss, Rosalynn Carter chair in mental health
Rollins School of Public Health, Emory University, 1518 Clifton Road, NE Room 606, Atlanta, GA 30322, USA bdruss@emory.edu
Steven C Marcus, research associate professor
School of Social Work, University of Pennsylvania